University of Toronto, Ontario, Canada.
J Rheumatol. 2010 Feb;37(2):446-7. doi: 10.3899/jrheum.090954.
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) is an international group dedicated to improving the lives of patients suffering from psoriasis and psoriatic arthritis (PsA). At the 2008 annual meeting of GRAPPA in Leeds, United Kingdom, members reviewed the status of imaging, including a new ultrasound measure, ultra-short echo time (UTE), and magnetic resonance imaging (MRI) in PsA and the imaging of musculoskeletal tissues in psoriasis; discussed the value and current status of composite measures for the assessment of PsA, including a breakout session where members addressed several issues related to developing PsA-specific composite measures; and reviewed biomarker development in psoriatic disease, including an interactive section on design considerations for a longitudinal study of biomarkers for joint damage. Summaries of those discussions are presented in this supplement.
银屑病和银屑病关节炎研究和评估组织(GRAPPA)是一个致力于改善银屑病和银屑病关节炎(PsA)患者生活的国际组织。2008 年,GRAPPA 在英国利兹举行的年会上,成员们回顾了影像学的现状,包括新的超声测量方法——超短回波时间(UTE)和磁共振成像(MRI)在 PsA 中的应用,以及肌肉骨骼组织在银屑病中的影像学表现;讨论了评估 PsA 的综合指标的价值和现状,包括一个分组讨论环节,成员们讨论了与开发特定于 PsA 的综合指标相关的几个问题;并回顾了银屑病疾病中的生物标志物开发,包括一个关于关节损伤生物标志物纵向研究设计考虑因素的互动环节。本增刊介绍了这些讨论的总结。